Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,227.99
(
0.28%
)
News Focus
News Focus
Post# of 257627
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 176909

Sunday, 04/20/2014 10:11:27 PM

Sunday, April 20, 2014 10:11:27 PM

Post# of 257627
ABT’s Business Segments 1Q14 
  
                         %Total   % Segment 
 Business segment         Sales   from Ex-US 
 Drugs*                    21%      100% 
 Laboratory diagnostics    17%       80% 
 Pediatric nutrition       17%       60% 
 Adult nutrition           14%       55% 
 Vascular devices          14%       64% 
 All other                 15%       58% 
                          ====      ==== 
 TOTAL                    100%       72%
*Branded generics.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today